Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000460170 | SCV000552266 | uncertain significance | Tuberous sclerosis 1 | 2018-01-17 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000460170 | SCV001137929 | likely benign | Tuberous sclerosis 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV001703175 | SCV002009244 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000460170 | SCV002040044 | uncertain significance | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002429538 | SCV002744644 | benign | Hereditary cancer-predisposing syndrome | 2020-07-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001703175 | SCV004032894 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | TSC1: BP4, BS1 |
Color Diagnostics, |
RCV000460170 | SCV004360808 | likely benign | Tuberous sclerosis 1 | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001703175 | SCV001929634 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001703175 | SCV001969851 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003912811 | SCV004729313 | benign | TSC1-related disorder | 2020-12-09 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |